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Background: Bacillus subtilis strains produce a broad spectrum of lipopeptides 
that are potent biosurfactants and have specific antimicrobial and antiviral 
activities. The cyclic lipodecapeptide fengycin is one such compound. Although 
the fengycin biosynthetic genes in 6. subtilis 168 (pps genes) and F29-3 (fen 
genes) have been well characterized, only limited information is available about 
the biochemical features of the fengycin synthetase multienzyme system. 
Results: Five multifunctional peptide synthetases (Fen1 -5) that catalyze 
biosynthesis of the peptide portion of fengycin have been purified from crude 
extracts of the B. subtilis b213 and Al /3 strains. These enzymes activate all 
fengycin amino-acid components as aminoacyl adenylates or aminoacyl 
thioesters. Fen1 , Fen2 and Fen3 are each -286 kDa, Fen4 is -400 kDa and 
Fen 5 is - 140kDa; each enzyme activates a different set of L-amino acids. A 
five-gene cluster (fen1 -5) was detected in the B. subtdis Al 13 genome that 
shows high homology to the pps and fen genes in B. subtilis strains 168 and 
F29-3. Disruption of fen4 resulted in a loss of fengycin production. The fengycin 
synthetase enzymes isolated from B. subtilis b213 were assigned to the 
corresponding Al /3 fen genes by their amino-terminal sequences. 
Conclusions: The structural and functional organization of the fengycin 
synthetase system from B. subtilis b213 has been characterized in detail and 
correlated with the corresponding pps and fen genes in B. subtilis strains 168, 
Al 13 and F29-3. Biosynthesis of the peptide part of fengycin involves five 
multifunctional modular proteins that assemble the lipopeptide chain using a 
nonribosomal, multiple carrier thiotemplate mechanism. 
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Introduction 
Batiks subtilis strains are a rich source of bioactive pep- 
tides with a high potential for biotechnological and phar- 
maceutical applications. The lipopeptides (surfactin [l-7], 
fengycin [8] and the members of the iturin family - iturin, 
mycosubtilin and bacillomycin) are a prominent class of 
such compounds [9-121. The plipastatins, which are very 
similar to fengycin. have been isolated and characterized 
from B. cereus by CJmezawa’s group [13-171. All of these 
agents represent amphiphilic, membrane active biosurfac- 
tants and peptide antibiotics with specific antimicrobial 
activities. Fengycin (Figure 1) is a cyclic lipodecapeptide 
containing a /Shydroxy fatty acid with a sidechain length of 
16-19 carbon atoms. Four [l-amino acids and ornithine (a 
nonproteinogenic residue) have been found in the peptide 
portion of fengycin. It is specifically active against filamen- 
tous fungi [8,18] and inhibits the enzymes phospholipase 
AZ [13-151 and aromatase [19]. Like the other lipopeptides 
produced by B. stlbtilis, fengycin appears as a mixture of 
isoforms that show variations in both the length and 
branching of the P-hydroxy fatty acid moiety. as well as in 
the amino-acid composition of the peptide ring [8,14,1.5]. 
For example, at position 6 t)-alanine (as in fengycin A) can 
be replaced by D-valine (as in fengycin B). 
In the framework of the: European B. subtilis genome 
sequencicg project, a second large operon structure (pps) 
was detected in the chromosome of B. subtilis 168 that 
encodes a peptide-forming multienzyme system [20,21] in 
addition to the surfactin biosynthetic operon (SY$ [Z&23]). 
The pps Dperon is 37.8 kilobases (kb), and contains five 
open reading frames (ORF’s) that comprise ten amino-acid 
activating modules in total. Because of its organizational 
features, pps was assigned to fengycin biosynthesis, even 
though B. mbdis 168 does not produce this lipopeptide. 
Chen et al. [24] detected :i gene cluster (the fen genes) in 
the genorne of the fengycin producer B. sub&is F29-3 that 
showed h[gh homology and a similar organization to the cor- 
respondingpps genes in B. subtilis 168. Disruption of one of 
theh9z genes prevented fengycin production, providing evi- 
dence that these genes are involved in this process [25]. 
Analysis of thepps andfen genes revealed a modular struc- 
ture characteristic of multifunctional peptide synthetases 
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that use the multiple carrier thiotemplate mechanism 
[26,27]. Such multienzymes activate their substrate amino 
acids using a two-step mechanism, first as aminoacyl 
adenylates (an ATP-dependent reaction) and then as amino- 
acyl thioesters. Multiple 4’-phosphopantetheine cofactors. 
one at each reaction center, function as the thiotemplate 
sites and manage assembly of the growing peptide chain in 
a series of transpeptidation reactions. Such multienzymes 
consist of 1000-1500 amino-acid residue modules that can 
be divided into three main sections responsible for sub- 
strate recognition and binding, as well as aminoacyl adeny- 
late formation; thiolation of the amino-acid substrates; 
and peptide elongation (in some cases, the third section is 
also responsible for epimerization). Each module is distin- 
guished by a linear array of highly conserved consensus 
motifs, which form the cores of multifunctional domains 
involved in the biosynthetic process. These reactive struc- 
tural elements are arranged in series along the multifunc- 
tional polypeptide chains like assembly points on a produc- 
tion line. Peptide synthetases, therefore, can be regarded 
as cellular factories. 
In contrast to the structure of the fengycin biosynthetic 
genes, not much is known about the biochemical features 
of fengycin synchetase at the protein level. In this paper, 
therefore, we investigated in detail the structural and 
functional organization of this multienzyme system from 
the fengycin-producing strains H. subtilis 1,213 and Al/.X 
Results 
Detection of fengycin and surfactin production of 
6. subtilis b213 and Al/3 
Lipopeptide production in B. subtj/iT strains b213 and Al/3 
was investigated using chromatographic procedures and 
matrix-assisted l.aser desorption/ionization mass spectros- 
copy &IALDI-hIS). Acid precipitates of the culture super- 
natants were extracted with methanol and detected by 
thin layer chromatography (TLC) on silica gel DC 60 
plates. Seven prominent spots were visible, by charring 
with sulfuric acid, in the extracts of both strains. Spots 1-4 
had R, values of 0.07, 0.09, 0.11 and 0.14 and were stained 
by ninhydrin, whereas :jpots S-7 (R, values of 0.59, 0.75 
and 0.8) were ninhydrin negative. 
In Figure 2a hlALDI-time-of-flight (TOF) mass spectra 
of the lipopeptide fraction corresponding to spots 1-4 of 
B. sujltihls bZ1.3 (spectrum i) and Al/3 (spectrum ii) are 
shown. The mass spectrum of the mutant strain A1/3: 
SD85 (in which ORF4 of the pps-like operon has been 
disrupted) is also shown (spectrum iii). The mass spectra 
of spots l-4 from the two wild-type strains are very 
similar. In the linear mode we observed a clusters of 
peaks with mass/charge (m/z) ratios between 144Y.6 and 
1557.9, which could be attributed to protonated fengycin 
isoforms and their alkali metal adducts. For example, the 
peak with a m/z of 1451.1 corresponds to the mass of the 
[M+H]+ ion of fengycin with a fatty acid chain length of 
16 carbon atoms. Structural characterization of this 
isoform was performed by monitoring and analysing the 
fragmenr ions obtained from MALDI-post source decay 
(PSD) mass spectra (Figure Zb). 
Isolation and characterization of fengycin synthetase from 
a cell free system of 6. subtilis b213 
We studied the structural and functional organization of the 
fengycin synthetase from 1?. subdis b213. In order to charac- 
terize this multienzyme system, cell-free extracts were pre- 
pared by first incubating the cells with lysozyme, and then 
fractionating the extracts using size-exclusion chromatog- 
raphy on Ultrogel AcA 34. The different fractions were 
screened for thioester-formation reactions with all fengycin 
amino-acid components. Three high molecular enzyme 
fractions were obtained (Figure 3). Fraction I appeared near 
the exclusion limit of the column, and showed thiolation of 
I,-proline, I,-glutamine, and I,-tyrosine residues. Fractions II 
and III elutcd at positions chat corresponded to lower mass 
numbers. Fraction II activated I>-tyrosine, ornithine, L-glu- 
tamate, I.-alsnine. I=threonine and I,glutamine. Fraction 
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MALDI-TOF-MS analysis of surfactin and fengycin production by culture supernatant. After a proline-directed fragmentation, series of 
various 6. subtilis strains. (a) MALDI mass spectra of fengycin in the amino-terminal (b,) and carboxy-terminal (Y,) sequence ions were 
lipopeptide fraction of culture supernatants from (i) B. subfilis b213, obtained. In order to confirm the structure of fengycin, we compared 
(ii) B. subtilis Al /3 and (iii) the mutant A1/3sd85, bearing a gene the observed m/z values with the theoretical values for the b, and Y, 
disruption in ORF4 of the pps-like operon of E. subtilis Al 13. sequence ions of a fengycin isoform containing a P-hydroxy fatty acid 
(b) Structure of fengycin as determined using MALDI-PSD analysis of (/3-OH-FA) with 16 carbon atoms. The limit of error of the PSD MS 
the peak at m/z = 1451 .l in the mass spectrum of the 6. subtilis b213 measurements was dz 0.2%. Single-letter amino-acid #code is used. 
III contained an I,-isoleucine-activating enzyme that eluted 
at a position that corresponded to a molecular mass of 
- 120-160 kDa. 
Multienzyme fraction I, obtained by ,4cA 34 gel filtration, 
was purified successively using fast protein liquid 
chromatography (FPLC) MonoQ and SmartQ. The 
anion-exchange chromatography experiment using the 
high resolution Pharmacia Smart System is shown in 
Figure 4. Thioester-formation reactions with the sub- 
strate amino acids r2-tyrosine. I,-glutamine and I,-proline 
were measured in the gradient fractions, showing their 
maximum at the same position. The specific activities of 
thioester binding of I,-tyrosine and L-glutamine were 
higher than that of r,-proline. Possibly, the proline-depen- 
dent activity is more impaired by sodium chloride used as 
gradient material in ion-exchange chromatography. In 
these fractions no thioester-binding activity was found 
with L-glutamate. A protein band with a molecular mass 
of -400 kDa is apparent from the SDS-PAGE (Figure 4). 
Its mobility is comparable with surfactin synthetase 2 
(SrfA, 401 kDa), a multienzyme comprised of three 
amino-acid activating modules. 
The enzymes responsible for the amino-acid activation 
reactions shown by fraction II were additionally purified 
using high-resolution anion-exchange Pharmacia FPLC 
on ResourceQ. Three multifunctional protein compo- 
nents of fengycin synthetase were highly purified and 
finally separated using chromatography on I;PLC MonoQ. 
The enzymes were localized in the elution pattern of the 
MonoQ column by their thioester-formation reactions with 
I,-alanine, I>-tyrosine, r,-glutamate, L-threonine, I.-valine and 
I,-ornithine (Figure 5). The protein that elutcd at the lowest 
ionic strength shows thioester formation with I,-tyrosine 
and I,-threonine, followed by the two other fengycin syn- 
thetase conponents at slightly higher NaCl concentrations. 
The protein that eluced at the medium position thiolates 
I,-valine, I,-alanine and I,-ghrtamic acid, whereas the enzyme 
that appeared at the higher ionic strength forms thioesters 
with I,-glutamic acid and I,-ornithine. All these synthetases 
have nearly the same mobility in the SDS-polyacrylamide 
gel, indicating that the molecular mass of each of these 
enzymes is -285 kDa (Figure 5). 
Fraction III, which contains an isoleucine-activating 
enzyme, nas further purified using anion-exchange FPLC 
on ResourceQ, then size-exclusion chromatography using 
Pharmacia Sephacryl-200, and finally high-resolution anion- 
exchange FPLC on Pharmacia hlonoQ (Figure 6). This 
protein eluted from the MonoQ column at lower salt con- 
centrations than all other components of the fengycin mul- 
tienzyme system. It activates I,-isoleucine as a thioester, but 
none of the other fengycin amino-acid components. It was 
labeled by thiolation with r.-[14C]-IIe. The molecular mass 
of the labeled enzyme was determined using SDS-PAGE 
(-140 kDa; Figure 6, lane FL). No r,-[14C]-Ile incorporation 
was detectled in the absence of A’I’P. 
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Gel filtration of a crude cell-free extract of B. subtilis b213 on Ultrogel 
AcA 34. Three enzyme fractions (l-111) of fengycin synthetase were 
obtained from thioester-binding studies using all the substrate amino 
acids. The elution buffer was 50 mM Tris-HCI, pH 7.5, 5 mM DTE, 3 mM 
EDTA containing 10% sucrose. The flow rate was 100 ml/h. 
Detection and reconstruction of the fen gene cluster in 
B. subtilis A1 13 
In order to correlate the protein equipment of the fengycin 
synthetase multienzyme system from B. s&Us bZ13 with 
the corresponding fen (pps) genes we used B. su&%s Al/3 
rather than the well known strain 168, which does not 
produce fengycin. B. szlbUs b213 and Al/3 have very 
similar lipopeptide spectra. Both strains efficiently produce 
fengycin as demonstrated above, but in contrast to B. sub- 
&s b213, the Al/3 strain is transformable and so more 
amenable to gen’etic manipulation. We screened the Al/3 
genome for the fengycin biosynthetic genes using a poly- 
merase chain reaction (PCR)-based cloning strategy previ- 
ously used to detect peptide synthetase genes; degenerate 
primers representing the amino-acid motif ‘TGD’ (forward 
primer; using single letter amino-acid code) and ‘LGG’ 
(reverse primer), derived from known conserved consensus 
sequences, were used [28,29]. We were able to amplify and 
clone a large number of DNA fragments. Sequence com- 
parison revealed that four of the PCR fragments (SDBS, 
SD87, SD292 and SD21) of B. sz&~ll;. Al/3 DNA exhibited 
pronounced homology to peptide synthetases encoded by 
ORF4 (genepps4) and ORFl (gene pps2) of the pps operon 
of B. .sz&& 168 (E:MBL entry 234883 [ZZ,Z3]). 
Fragment SD85 was -500 base pairs (bp) long. It was 
therefore expected to span the core sequences TGD and 
LGGXS (where X is mostly a histidine or aspartic acid 
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High-resolution anion-exchange FPLC of the fengycin synthetase 
component in fraction I on Pharmacia SmartQ. This protein, which 
was purified by AcA 34 gel filtration and anion-exchange FPLC on 
Pharmacia MonoQ, was rechromatographed on Pharmacia Smart0 
(a) Coomassie-stained 5% SDS polyacrylamide slab gel showing the 
protein composition of fractions tested for substrate amino-acid 
incorporation. Marker proteins: gramicidin S synthetase 2 (GS2, 
508 kDa), WE-protein (401 kDa), myosin (205 kDa), P-galacto- 
sidase (116 kDa), phosphorylase b (97.4 kDa) and bovine albumin 
(66 kDa). (b) The fractions were tested for covalent incorporation of 
L-[14ClTyr, L-[J4CIGln, and L-[14ClPro as outlined in the Materials and 
methods section. 
residue) within a single peptide synthetase module. The 
other PCR fragments, SD87, SD292 and SD21 (Figure 7), 
were -4 kb in size. Presumably, in these cases, a piece of 
DNA was amplified extending from the TGD motif of a 
peptide synthetase up to the LGGXS motif in either the 
preceding or the following module. Overlapping sequence 
regions on fragments SD85 SD87 and SD292 allowed us 
to localize them to a region spanning -8 kb of DNA from 
the 3’ end of ORF3 to about half of ORF4. l’he SD87 
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Figure 5 
Separation of the fengycin synthetase 
components in fraction II by anion-exchange 
FPLC on Pharmacia Monoa 5/5. These 
proteins, which were purified by AcA 34 gel 
filtration and anion-exchange FPLC on 
Pharmacia ResourceQ, were rechromato- 
graphed on Pharmacra MonoQ. They were 
eluted from the column with a linear gradient of 
O-O.5 M NaCl in 50 mM Tris/HCI, pH 7.5, 
containing 5 mM DTE. The flow rate was 1 
mllmin and the fraction size 1 ml. (a) All three 
enzymes were tested for thioester formation 
with amino acids l-6 of fengycin: L-alanine, L- 
tyrosine, L-glutamate, L-threonine, L-valine and L- 
ornithine. (b) A 50/, SDS polyacrylamide slab 
gel of the fractions showing maximal thioester- 
binding activities with L-tyrosine, L-valine and L- 
ornithine, respectively. Marker proteins: 
gramicidin S synthetase 2 (GS2, 508 kDa), 
SrfB-protein (401 kDa), myosin (205 kDa), 
P-galactosidase (116 kDa), phosphorylase b 
(97.4 kDa), and bovine albumin (66 kDa). 
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fragment should therefore include the region correspond- 
ing to the 5’-terminal portion of the pps4 gene of B. subtilis 
168. The 5’- and 3’-terminal portions of fragment SD21 
extend from one thiolation motif GGXSL to the following 
and showed the highest homology topps/. 
From these initially cloned and sequenced DNA regions 
we then amplified ‘outside’ DNA by primer walking using 
only one specific primer (which apparently functioned as 
forward as well as reverse primer) for that corresponding 
DNA region. The amino-terminal region Nl and N2 from 
gene pps! and ppsi’, respectively, were amplified from 
fragment SD21 in either 5’ or 3’ direction. The N3 region 
of gene pps.? was obtained by primer walking from frag- 
ment SD87 generating also fragment A42 in 5’ direction. 
The N4 region was found in fragments SD87 and A23 and 
the I\;5 region of genepps5 after primer walking from frag- 
ment SD292 up in 3’ direction (Figure 7). Knowledge of 
these DhA fragments allowed us to propo:se the putative 
gene organization and module structure of a gene cluster 
in the genome of B. slcbtilic A1/3, which shows a high 
homology to thepps operon in the 168 reference strain. 
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1200 L d L-lie * 
(b) kDa M A B 
II 
Figure 6 
Anion-exchange FPLC of the fengycin 
synthetase component in fraction Ill on 
Pharmacia MonoC. This protein was purified by 
AcA 34 gel filtration, anion-exchange FPLC on 
Pharmacia Resourcea, gel filtration on 
Sephacryl S-200 and finally by high resolution 
anion exchange chromatography on MonoC. 
The protein was eluted from the MonoQ 
column with a linear gradient of O-O.5 M NaCl 
in 50 mM TrislHCI, pH 7.5, containing 5 mM 
DTE. The flow rate was 1 mllmin, the fraction 
size 1 ml. (a) The protein was tested for the 
incorporation of both L-[‘4CI-lle and L-[r4C]-Tyr. 
(b) A 12.5% SDS polyacrylamide slab gel 
showing the proteins in fraction 31, which 
exhibits maximal thioester formation with L- 
[r4CI-lie (lane A), an autoradiogram of this 
fraction with L-[‘4C]-lle as tracer (lane B) and 
marker proteins (lane M) myosin (205 kDa), 
P-galactosidase (116 kDa), and phosphorylase 
b (97.4 kDa). Details of autoradiography are in 
the Materials and methods section. 
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Construction of a 6. subtilis Al/3 ORF4 bps4 gene) 
disruption mutant 
The involvement of the putative pps gene cluster of 
B. suhtih Al/3 in fengycin biosynthesis was demon- 
strated by constructing a B. .whdis Al/3 gene disruption 
mutant. The pMOS vector, which contained the 500 bp 
SD85 fragment, was ligated to plasmid pElY4 (which 
confers resistance to erythromycin both in E. roli and in 
B. suhtilis). The resulting plasmid pMOS-SD85pEl94 
was transformed into B. subti~‘is Al/3 at 30°C; chromoso- 
ma1 integration of the plasmid was achieved by selecting 
for erythromycin resistance after repeated rounds of cul- 
tivation at 52°C. Integration of the plasmid was con- 
firmed by Southern blot hybridisation with digested 
chromosomal DNA of the putative integration mutant 
and the SD85 DNA fragment for a probe. Disruption of 
the wild-type DNA fragment, presumably in ORF3 of 
the B. subtihs Al/3 fen gene cluster was indicated in the 
mutant A1/3-sd5.S by the appearance of new hybridising 
fragments (data not shown). 
The A1/3-sd85 mutant was tested for fengycin production 
in ammonium citrate/sucrose (ACS) medium using TLC 
and MALDI-MS analysis in the same manner as performed 
for the wild-type strain. Fengycin was not detected by the 
TLC in the mut.ant strain. Also, in the MALDI mass spec- 
trum, the fengycin cluster was lacking in the lipopeptide 
extract of the mutant strain (Figure Za, spectrum iii). These 
results support the idea that theppi-like operon in B. sz&ilis 
Al/3 encodes the fengycin biosynthetic genes. 
Correlation of the fengycin synthetase subunits from 
B. subtilis b213 to the corresponding pps and fen genes 
using amino-terminal sequences 
All fengycin synthetase components from B. suhtilis b213 
were further purified to SmartQ grade. They were 
blotted from preparative SDS polyacrylamide gels onto 
polyvinylidene difluoride membranes for amino-terminal 
sequencing by Edman degradation. These sequences are 
summarized in Table 1. At least ten arnino acids were 
sequenced for each of the proteins and revealed nearly 
100% identity with the corresponding segments derived 
from the fen genes of B. suhihs A1/3. Comparing these 
protein sequences with the DNA sequences of the pps 
and fen genes from B. mhtih strains 168 and F29-3 also 
allowed the purified fengycin synthetase components 
to be reliably identified (Table 1). The pps genes from 
B. sz&iA;s 168 have been sequenced, and the predicted 
protein sequences of rhe Ppsl-5 products (P39845, 
P39846 and P39847 in the Swiss-Prot databank [Z]; 
Y13917 in the EMBL databank [23]) are 66, 60, 100, 80 
and 58%, respectively, identical with our protein sequences. 
The B. suMis F29-3, FenE (AF02346.5; GenbankTM), 
FenA (AF023464; GenbankTM), and FenB (L42523; 
EMBL databank [30]) proteins have 100, NO and 66% 
identity with the corresponding segments of the fengycin 
synthetase component enzymes from B. suh’lis A1/3. 
The sequence of the Fcn3-related genes did not vary 
between the strains. 
Discussion 
Badas suhtilis is one of the most prominent peptide- 
forming cell factories hitherto known. In particular, its 
lipopeptide products (the surfactins, fengycins and the 
members of the iturin family) are valuable, industrially 
important compounds. They represent potent biosurfac- 
tants and show efficient antimicrobial and antiviral proper- 
ties [31-.X3]. They are synthesized by large multienzyme 
systems that have a modular structure [26,27]. Both their 
commercial exploitation and elucidation of the synthetic 
mechanism of lipopeptide biosynthesis in B. szdtilis 
require knowledge about the sequence and organization 
of the biosynthetic genes, as well as about: the structure 
and function of the corresponding peptide synthetases. 
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Table 1 
Amino-terminal sequence alignment of fengycin synthetase subunits from various Bacillus strains. 
Gene product B. subtilis strain Amino-terminal sequence Identity (o/o) Homology (o/o) 
Fen1 213 
Al /3orfl All3 
Ppsl 168 
Fen2 
Al l3orf2 
PpsP 
213 TQATEIQDIY 
All3 MTQATEIQDIYFLSYMQEGNLFHSLLDSGS-30 
168 MTQSAQI~DIYPLSHMQEGMLF?ISLMDFSS 
Fen3 
Al l3orf3 
Pps3 
FenE 
213 
Al/3 
168 
F29-3 
Fen4 
Al l3orf4 
Pps4 
FenA 
213 
All3 
168 
F29-3 
Fen5 
A 1/3orf5 
Pps5 
Fen6 
213 
All3 
168 
F29-3 
MENTVYSLTHAQ 
MXNTVYSLTHAQRRVWFTELLEPC~TSICNL-30 
MSEHTYSLTHAPR!~VI~JFTELLEI'TIT;lCNL 
QQFEIQDIYPLSFMQ 
MGQQPEIQDIYPLC:FMQEGMLFhSLLDHDS-30 
MPQQPEIQDIYPLC,FMQEGMLFHSLYDEQS 
MPQQPE1QDIYPLSFMQEGMLFHSLYDEQS 
l'KKNAIQD:V 
MTKKXAIQDIYP'SYMQEGMLFHS;LQKES-30 
M'I'KANSlQDIYPLSYMQEGMLFHS.,LQKDS 
M'rE;ANS~QDIYPl,SYMQEC-LLFHSI,L'~KDS 
MDKTKNIQNIYP 
~KT~;NIQNIYPI,SlWQE:GMLFH!XLQKEG-30 
MNTIEXIKNIYPI~SHMQEGMLFH:;E'LRKEE 
MVKTKKIKNIYPLSHMQE~GMLFHSE‘LHKEE 
100 100 
58 58 
100 100 
60 80 
100 
100 
100 
100 100 
80 90 
80 90 
100 100 
58 75 
66 83 
100 
100 
100 
Identical positions in all available sequences are in blue. Accession numbers and references for the published gene sequences: pps7, P39845 
[22]; pps.2, P39846 [22]; pps3, P39847; pps4, Y13917; pps.5, Y13917 [23]; fenA, AF023464; fenB, L42523 [30]; fenE, AF023465. 
To this end we studied the biosynthesis of fengycin in the 
B. szrbtilis strains b213 and A1/3. llsing MALDI-MS we 
demonstrated that both strains have a very similar lipopep- 
tide spectrum, fengycin being one of the prominent prod- 
ucts. The structural and functional organization of the 
fengycin-producing multienzyme system was investigated 
in B. stl/,ticis b21.I It was demonstrated that five enzymes, 
Fenld, are involved in the assembly of the peptide part of 
this lipodecapeptide. All of the fengycin amino-acid compo- 
nents are activated as aminoacyl adenylates and aminoacyl 
thioesters according to the two-step thiotemplate mecha- 
nism [Zh]. Corresponding proteins have also been isolated 
and purified from B. subtdis Al/3. Genetic studies on the 
biosynthesis of fengycin have been performed with this 
strain because, in contrast to B. subtijl’is b213, it is trans- 
formable and therefore amenable to genetic manipulation. 
Our gene-sequencing studies and the characterization of the 
fengycin nonproducing gene-disruption mutant A1/3-sd8.5 
revealed that B. subtih All.3 contains a complete operon- 
encoding fengycin production that has high homology to the 
pps operon from B. sub.dis 168, as well as to the fen genes 
(investigated by Liu ef al. [24,25] in B. subtilis F29-3). The 
#s operon has been completely sequenced in the frame- 
work of the European B. subdis genome project [ZZ,23]. 
The reference strain B. .wbtiliT 168 does not produce 
fengycin, but obviously contains fengycin biosynthetic 
qenes. The FZ9-3 strain, however, is a fengycin producer. 
We identified the fengycin synthetase components puri- 
tied from cell-free extracts of B. subtilis bZl3 by amino- 
terminal sequencing and comparison of these results 
with the ,<ene sequences of the pps and .fpz operons from 
the B. subtilis strains 168, A113 and F29-3. There is 
perfect agreement between our proteinchemical data 
with the amino-terminal sequences derived from the 
fengycin biosynthetic genes of the Al/3 strain and high 
homology to the sequences available from thepps andfen 
operons in the other two strains. 
By correlating the characteristics of fengycin synthetase at 
the level of both protein and DNA, the structural and func- 
tional organization of this multienzyme sy:item becomes 
apparenr (Figure 8). The p@.r and ftn operons include five 
open reading frames that comprise ten amino-acid activat- 
ing modules. The first three genes encode three proteins 
of similar size (fengycin synthetase 1-3, Fen]-3). Each 
protein cot- sists of two modules that in turn activate amino- 
acid components l-6 of fengycin. Fen1 activates glutamate 
(position 1) and ornichine (position 2) which form the 
sidechain of fengycin. Fen2 activates and incorporates 
tyrosine (position 3) and allo-threonine (position 4). Fen3 
incorporates glutamate (position 5) and valine or alanine 
(position 6). These four amino acids are integrated into its 
peptide ring. The Fen12 genes are followed in the 
fengycin operon by a larger ORF, which codes for a thrce- 
module enlyme (Fenl) that activates proline (position 7). 
glutamine (position 8) and tyrosine (position 9); the final 
and smalles: ORF in the operon encodes Fen.5, which acti- 
vates isoleucine (position 10). Fen.5 is presumably involved 
in closing the fengycin ring by facilitating lactone forma- 
tion between the carboxyl functional group of I,-isoleucine 
and the hydroxyl group of I,-tyrosinc in position 3. Each of 
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Figure 8 
Fen1 Fen2 
!; D;a~ Fen3 
C,,-C,S~HCH,CO-~&~- C&II- L+yr - odThr- 0% - DAla 
OH 6 I 
Fen5 &-- DTyr - LGln-d&o 
10 9 B 
--___ 
Organization of the fengycin synthetase multienzyme system 
Fen14 contains an epimerization domain in their car- 
boxy]-terminal module that catalyzes the conversion of 
amino acids 2, 4, 6 and 9 into their I>-enantiomers. Obvi- 
ously, the amino-acid activating modules of fengycin syn- 
thetase are arranged in the same sequence as the amino- 
acid components of the fengycin product. 
The FenB protein from strain FZ9-3 has recently been 
overexpressed in Es&r&a CO/~ and tested for its adenyla- 
tion and thioester binding specificity by Lin et a/. [30]. 
These experiments revealed that FenB has a high affinity 
for L-isoleucine and corresponds to the putative ppsK gene 
product from B. sz&Zs 168 and Fen5 from R. .r~btil’ic b213. 
FenB contains a thioesterase domain that is usually found at 
the carboxy-terminal end of the last module of prokaryotic 
peptide synthetases. These authors therefore suggested 
that FenB is involved in the terminal event of fengycin 
biosynthesis, which is the cyclization of the lipopeptide ring 
by lactone formation [30]. Fengycin formation is initiated 
by the transfer of the P-hydroxy fatty-acid component to the 
starting amino acid, I,-glutamic acid, by an acyltransferase, 
in a similar way as in the biosynthesis of surfactin [34]. This 
acyltransferase has not yet been identified, however. 
Our structural analysis of fengycin, using MALDI-MS, in 
combination with enzymatic studies on the amino-acid acti- 
vation pattern Iof fengycin synthetase is consistent with the 
structures originally reported for fengycin by Vanittanakom 
and I,oeffler (81 and for the plipastatins by Umezawa’s 
group [13-161. In contrast, the amino-acid sequence of 
fengycin proposed by Tosato et al. [23] (derived from 
sequence homologies of the amino-acid recognition regions 
in the B. szlhrir’ic 168 pps genes compared with the gene 
structures of other peptide synthetases) conflicts with all of 
these results. Tosato etal. [23) argued that PpsE would be 
responsible for .activating I,-tyrosine instead of I,-isoleucine; 
in their conclusions, L-isoleucine would be activated by the 
first module of PpsB. In addition, they proposed that the 
positions of II-Ala/t)-Val (position 6) and D-Tyr (position 9) 
would be revers;ed. Our results make the view of Tosato et 
al. [23] improbable, and suggest that it is not yet possible to 
identify unequivocally which amino acid will be activated 
by a given peptide synthetase module from sequence 
homology considerations alone. Furthermore, it is difficult 
to understand how the fengycin ring could be closed by 
lactone formation if I>-tyrosine in position 3 and I,-iso- 
leucine in position 10 were interchanged. 
Our results should facilitate the design and construction 
of recombinant peptide synthetases using module and 
domain replacements, as well as site-directed mutagene- 
sis, in order to create novel lipopeptide products with 
improved surfrlctant, antimicrobial and antiviral activities. 
In addition, the lipopeptide-forming multienzymes of 
B. su&dis (including fengycin synthetase) qualify as model 
systems for investigating the mechanism of peptide biosyn- 
thesis in general. B. suhtdis provides a potential of at least 15 
amino-acid activation modules (from its lipopeptide multi- 
enzymes) that are combined in different and specific ways 
during the assembly of the various peptide synthetases. In 
this context, the fengycin system is of particular interest for 
investigating important questions such a.s the acyl-transfer 
reactions in the initiation process and the mechanism of 
subunit interactions in the elongation cycle. In B. su~tilis, 
analagous modules are used in modified forms for different 
biosynthetic processes (e.g. the glutamic acid activating 
units used in surfactin and fengycin biosynthesis, or gluta- 
mine- iand proline-activating modules in fengycin or iturin 
biosynthesis), a peculiarity that might be helpful in under- 
standing the structural elements that control subunit inter- 
action in these multienzymes. All of these questions can be 
approached efficiently using mutational studies in combina- 
tion with the analysis of peptide intermediates. For such 
studies the preparation and characterization of the wild- 
type multienzymes are indispensable prerequisites. 
Significance 
The research presented in this paper is part of a project 
to investigate comprehensively the biochemical features 
of lipopeptide-forming cell factories, as well as the 
sequence and organization of the corresponding gene 
clusters in Bacillus subtiiis. A more comprehensive 
understanding about these multienzyme systems is highly 
important to allow us to use lipopeptide compounds in 
the phamlaceutical and food industries, in plant protec- 
tion, as well as for the elucidation of the mechanism of 
lipopeptide biosynthesis. 
Here we studied the biosynthesis of the lipodecapeptide 
fengycin in the B. subtilis strains b213 and A1/3. The 
peptide portion of fengycin is assembled through the coop- 
eration of five multifuncrional enzymes (Fen14 using a 
multiple carrier thiotemplate mechanism. The structural 
and functional organization of this multienzyme system is 
consistent with the rules derived for prolcaryotic peptide 
synthetases. These proteins were correlated by their 
amino-terminal sequences with a cluster of five genes 
(fenl-5) in B. subtilis All3 that have been cloned and 
partially sequenced. They show high homology to the pps 
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and fen operons in B. subtifis 168 and F29-3. The rele- 
vance of these genes with respect to fengycin biosynthesis 
was ascertained by constructing a fengycin-deficient 
A1/3-sd85 gene-disruption mutant. Our results form the 
basis for the genetic engineering of this m&enzyme 
system to design novel biosurfactant agents with 
improved antimicrobial and antiviral activities. 
Materials and methods 
Materials 
L-[U-14C]glutamine (280 mCi/mmol), L-[U-14C]glutamate (249 mCi/mmol), 
L-[U-‘4Clthreonine (228 mCi/mmol), L-[U-r4C]tyrosine (464 mCi/mmol), 
L-[U-‘4C]alanine (156 mCi/mmol), L-[U-14C]isoleucine (330 mCi/mmol), 
L-[U-14C]proline (264 mCi/mmol), and L-[Ui4C]valine (262 mCi/mmol) 
were purchased from Amersham Life Sciences (Braunschweig, Germany). 
L-[2,3-sH]ornithine (53.4 Ci/mmol) was obtained from American Radiola- 
beled Chemicals (St. Louis, USA). Na,PsP]pyrophosphate (6.42 Ci/mmol) 
was a product of DuPont-NEN Life Science (Bad Homburg, Germany). 
Ultrogel AcA 34 was from BioSepra (Frankfurt a.M., Germany). Anion- 
exchange chromatography was performed using C-Sepharose Fast Flow 
and the FPLC columns MonoQ HR5/5, Resourcea, and SmartMonoQ 
PC 1.6/5 from Amersham Pharmacia Biotech (Freiburg, Germany). All 
other chemicals used were reagent grade. 
Strains and plasmids 
B. subtilis b213 was selected and characterized by Jacques et a/. [351. 
B. subtilis Al/3 has been isolated from greenhouse tomato cultures. It 
shows a broad spectrum of antibiotic activities against bacteria, fungi 
and plant viruses (E. Griesbach and A. HabekuR, personal communica- 
tions). Escherichia co/i XLl-Blue (New England BioLabs, Schwalbach, 
Germany) was used as host for PCR fragment cloning. 
Plasmids used in this study were pMOS-T vector (Amersham LIFE 
Sciences), pE194 1361, pMOSSD85, pMOSSD87, pMOSSD292, 
pMOSSD21 (pMOS derivatives with inserts of respective PCR 
fragments that showed homology to distinct peptide synthetase 
domain regions) and pEl94-pMOSSD85 (shuttle for gene disrup- 
tion mutagenesis). 
Fermentation of Bacillus subtilis b273 
Bacillus subtilis b213 was cultivated in an optimized sucrose/yeast 
extract/peptone medium [35] and Bacillus subtilis Al/3 in an ammonium 
citrate medium [371. Cells of B. subtdis b213 used for enzymatic studies 
were grown in a 300 I fermenter (Biolafitte, France) containing 150 I 
medium under pH control (pH 7) with an aeration of 1 wm and an agita- 
tion of 150 rpm at 30°C. Cells (2.3 kg) were harvested 23 h after inocula- 
tion by centrifugation, when the OD,,, was 6.27, and stored frozen. 
TLC and MALDI-TOF-MS analysis of culture medium 
extracts from Bacillus subtilis A 7/3 and 6273 
Lipopeptides were precipitated from 4 I of culture supernatant after HCI 
acidification (to pH 2). The precipitate was resuspended in a minimal 
amount of water, neutralized with NaOH and lyophilized. The lyophilisate 
was extracted with methanol and the extract applied on a LH-20 size 
exclusion column (Pharmacia, column size 1500 x 15 cm) using methanol 
as the eluent. Fractions containing fengycin were visualized using TLC. A 
mixture of chloroform:MeOH:water (65:25:4) was used as the mobile 
phase. Silica gel DC 60 plates from Merck (Darmstadt, Germany) were 
Jsed as the TLC matrix. Fengycin was visualized by treating with ninhydrin 
.snd charring with H,SO, and was further purified using reversed phase 
FPLC and high-performance liquid chromatography (HPLC) on a Pharma- 
cia PepRPC HR 1 O/i 0 column and on an ODS Hypersil column (Knauer, 
Herlin, Germany), respectively. A linear gradient of 20% acetonitrile in 
; 00 mM ammonium acetate (v/v), pH 6.9, and 100% acetonitrile was 
used for elution at a flow rate of 0.75 mllmin. Samples were scratched 
out from a nonsprayed TLC plate and eluted from the matrix with MeOH 
for MALDI-MS analysis. MALDI mass spectra were recorded on a Bruker 
Reflex MALDI-TOF instrument with a 337 nm nitrogen laser for desorp 
tion and ionization. A saturated solution of a-cyano-4-hydroxycinnamic 
acid in 70% acetonitrile/O.l% trifluoroacetic acid (v/v) was used as 
matrix. 10~s were accelerated with a voltage of 28.5 kV. The positive-ion 
detection and reflector mode was used. 
Enzymatk assays 
Substrate amino-acid dependent ATP-PP, exchange reactions and 
thioester binding of the amino-acid components of fengycin synthetase 
were mea.sured using the proc:edure described for the characterization 
of surfactin synthetase [34]. 
Enzyme preparation 
All steps were carried out at 4°C. B. subtilis b213 cells were suspended 
in 3 volumes of buffer A (50 mM Tris-HCI, pH 7.5, 5 mM DTE, 3 mM 
EDTA, 5 rrM benzamidine, and 20% sucrose). Protoplasts were gener- 
ated by lysozyme treatment (4000 U/ml cell suspension, 30°C, 20 min) 
and passed through a French press at a cell pressure of 18.000 psi. Cell 
debris was removed by centrifugation (25,000 g, 20 min). Nucleic acids 
were precipitated by addition of streptomycin sulfate to a final concentra- 
tion of 1 o/, (w/v) and stirring for 125 min. They were pelleted by centrifuga- 
tion at 25,000 g for 20 min. The proteins in the supernatant were salted 
out with ammonium sulfate at 70% saturation, dissolved in a minimum 
volume of buffer B (50 mM Tris-HCI, pH 7.8, 5 mM DTE, 3 mM EDTA, 
and 100/o sucrose), and dialysed against the same buffer. 40 ml of the 
crude enzyme extract was loaded on an Ultrogel AcA 34 column 
(75x5cm) and eluted with buffer B (flow rate lOOml/h, fraction size 
13 ml). Fractions in the high molecular weight range (z> 300 kDa) catalyz- 
ing thioester formation with proline, glutamine or tyrosine, as well as all 
fractions in The medium molecular weight range (200-300 kDa) showing 
thioester formation with glutamic acid, ornithine, tyrosine, threonine and 
alanine residues were pooled and assigned as enzyme fractions I and II, 
respectively. All of the fractions in the molecular mass range between 
100 and 2CO kDa that formed a thioester with isoleucine were pooled 
and designated as enzyme fraction Ill. 
Purification of Fen 1, Fen2 and Fen3 
Enzyme frac:tions I and II were loaded separately on a Resourcea 
column that was equilibrated with buffer C (50 mM Tris-HCI, pH 7.5, 
5 mM dithioerythritol, DTE). Proteins were eluted from the column with 
a linear gradient of O-O.5 M NaCI in buffer C (flow rate 2 mllmin, frac- 
tion size 2 ml, total volume 500 ml). Fractions containing enzyme activ- 
ity were pooled, diluted with 5 volumes of buffer C and loaded on a 
Mono0 column, Proteins were again eluted with a linear gradient of 
O-O.5 M NaCl in buffer C with a flow rate of 1 ml/min and a fraction 
size of 1 ml (lotal volume 200 ml). 
Purification of Fen4 
Fen4 was purified from enzyme fraction I by subsequent anion- 
exchange FPL.C on a Pharmacia MonoCl following the protocol described 
above. Fractions were tested for thioester binding activities. Active 
fractions were diluted five times with buffer C. The diluted pool was 
loaded on a SmartQ column using the Pharmacia Smart System. Fen4 
was eluted with a linear gradient of 200-400 mM NaCl in buffer C. The 
flow rate was 50 ul/min. 
Purification and autoradiographic analysis of Fen5 
Enzyme fraction Ill (L-lie binding activity) was loaded on a Resourcea 
column and cllromatographed as described above. Fractions showing 
L-lie thioester binding activity were pooled and concentrated to a volume 
of 5 ml using Centriprep concentrators with a cutoff of 100 kDa 
(Amicon GmbH, Witten, Germany). The concentrated protein was 
applied to a Superdex-200 gel filtration column (prep grade 16/60, 
Pharmacia) and eluted with buffer f3 containing 100 mM NaCl at a flow 
rate of 0.5 mkmin and a fraction size of 1 ml. Fractions containing 
enzyme activity were pooled and chromatographed on a Monoa column 
as described above. For autoradiography of a SDS gel containing the 
114C]-L-lle-labelsd protein 100 ul of protein fraction 34 from the Mono0 
separation were incubated in the presence of 0.05 uCi [r4C]-L-lie, 
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8.3 mM MgCI,, and 12.3 mM ATP in a total volume of 121 pl for 15 min 
at 37°C. The protein was then precipitated with trichloroacetic acid 
(TCA) overnight. The pellet was washed with acetone and resuspended 
in 20 PI Laemmli-SDS-PAGE buffer [381. The mixture was loaded on a 
5% polyacrylamide-SDS slab gel which was stained with Coomassie 
Blue and dried in a gel dryer. Finally it was subjected to autoradiography 
by exposure to X-ray film (Konica, Japan) for 4 weeks. 
Protein analysis 
Protein concentration was measured using the procedure of Bradford 
[39]. SDS-PAGE was performed according to Laemmli [381. Molecu- 
lar weights of denaturated proteins were determined with SDS-PAGE 
in a mini-gel apparatus (Hoefer, San Francisco, USA). Marker proteins 
were gramicidin S synthetase 2 (GS2, 512 kDa), surfactin synthetase 
3 (SrfB, 405 kDa), and a heigh molecular weight standard mixture. 
(30-200 kDa, Sigma, Deisenhofen, Germany). 
For amino-terminal sequence analysis, enzyme fractions obtained from 
high resolution anion-exchange FPLC on Mono0 were further purified 
with a Pharmacia Smart System using a SmartQ column. The samples 
were loaded on the column after dilution with 5 volumes of buffer C. 
Fen1 -3 and Ferl 5 were eluted with linear gradients of 200-400 mM 
NaCl and of 100-300 mM NaCl in buffer C, respectively. The flow rate 
was 50 pllmin. After preparative SDS-PAGE according to the proce- 
dure described in 134) the gels were electroblotted using a polyvinyli- 
dene difluoride membrane in a semi-dry Novablot apparatus (LKB, 
Bromma, Sweden) according to the protocols of the manufacturers. 
The blotted proteins were stained with a 0.20/o (w/v) Ponceau S solu- 
tion. Bands of the fengycin synthetase components were excised and 
submitted to Edman degradation.analysis using a Precise Sequencer 
(Perkin Elmer/Applied Biosystems, Weiterstadt, Germany). 
DNA manipulations 
B. subtilis Al/3 chromosomal DNA was prepared as described by 
Cutting and van cler Horn [401. Plasmid DNA was isolated from E. co/i 
by the alkaline lysis procedure and DNA manipulations were performed 
according to 14’11 and 1421. PCR fragments were purified with the 
CIIAEX gel elutiorl kit (QIAGEN, Hilden, Germany) and cloned by the 
pMOSB/ue-T vector kit (Amersham Life Sciences). Double-stranded 
DNA templates .for sequencing reactions were purified with the 
QIAGEN plasmid kit. 
Competent cells of f. co/i were prepared and transformed following 
the procedure of Hanahan [431. B. subtilis Al/3 was transformed with 
plasmid DNA by the protoplast method by Chang and Cohen [44]. 
PCR amplification 
To isolate domain fragments of peptide synthetases, PCR amplifica- 
tions were performed with 6. subtilis A113 genomic DNA using degen- 
erated primers ‘TGD’ (forward primer) and ‘LGG’ (reverse primer) as 
described by Turgay and Marahiel [28]. PCR was performed using Taq 
DNA polymerase and 10 x reaction buffer (Boehringer Mannheim, 
Germany). PCR was run for 35 cycles in a GeneAmp 2400 ThermoCy- 
cler apparatus (Perkin Elmer, Uberlingen, Germany) using the following 
protocol: chromosomal DNA 200-500 ng, primer and dNTP concen- 
tration 300 nM or 300 PM, respectively; denaturation: 5 min at 94°C in 
the first cycle and 30sec at 94°C thereafter; annealing: 30sec at 
55’C; elongation: 1 min at 72°C for amplification of 0.5 kb DNA frag- 
ments or 3 min at 5’2°C for amplification of DNA fragments 3-4 kb in 
size. For chromosomal walking, the long-range template kit from 
Boehringer Mannhelm was used for PCR amplification. 
Sequencing and sequence handling 
An automated A.L.F. DNA sequencer (Amersham Pharmacia Biotech, 
Freiburg, Germany) was used for nucleotide sequencing. Sequences 
were compared to those in EMBL databases using the BLAST e-mail 
server [45,46]. In Iparticular, we used BLASTN and BLASTX for 
homology searches of nucleotide and amino-acid sequence similari- 
ties, respectively. 
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